Evaluation of Patients Without Fever
The absence of fever does not exclude serious infection and should trigger a clinical assessment based on other signs of systemic illness rather than routine laboratory or radiologic workup. 1
Key Clinical Principle
Approximately 16-21% of patients with bacteremia and serious infections present without fever 2, 3. These afebrile patients actually have higher 30-day mortality (27.6% vs 10.1%) compared to febrile patients, likely due to delayed recognition and treatment 3.
Who Is at Highest Risk for Afebrile Infection?
Look specifically for these patient populations 1:
- Elderly patients
- Immunocompromised patients (including transplant recipients, cancer patients, those on immunosuppressants) 4
- Patients with open abdominal wounds or large burns
- Patients receiving extracorporeal membrane oxygenation or continuous renal replacement therapy
- Patients with congestive heart failure, end-stage liver disease, or chronic renal failure
- Patients taking anti-inflammatory or antipyretic drugs
Clinical Triggers for Infection Workup (Even Without Fever)
Base your decision to investigate for infection on these specific clinical findings 1:
- Hemodynamic instability: Unexplained hypotension
- Respiratory changes: Tachypnea, new respiratory symptoms
- Cardiovascular: Tachycardia
- Neurologic: New confusion or altered mental status
- Constitutional: Rigors
- Cutaneous: New skin lesions
- Renal: Oliguria
- Laboratory:
- Lactic acidosis
- Leukocytosis or leukopenia
- Bandemia ≥10%
- Thrombocytopenia
Specific Recommendations for Afebrile Patients
When to Pursue Aggressive Workup
If any of the above clinical triggers are present, proceed with comprehensive infection evaluation including blood cultures and empirical antibiotics, even in the complete absence of fever 1.
When NOT to Pursue Routine Testing
Do not order automatic laboratory or radiologic tests solely based on temperature thresholds 1. A temperature of 36.0°C or absence of fever is a reasonable trigger for clinical assessment but not for automatic lab or imaging workup 1.
Special Consideration: Immunosuppressed Patients
In immunosuppressed patients presenting to the emergency department without fever, measure procalcitonin to help identify occult serious infection and reduce diagnostic delay 4. These patients showed elevated procalcitonin, IL-6, and LDH levels even when afebrile, and mortality correlated with low albumin, oxygen saturation, platelet count, and elevated procalcitonin 4.
Critical Pitfall to Avoid
The most dangerous error is assuming that absence of fever means absence of serious infection. Afebrile bacteremic patients have significantly higher 30-day mortality (27.6% vs 10.1%) 3, yet they receive antibiotics at similar rates to febrile patients—meaning the increased mortality is likely due to delayed recognition rather than delayed treatment once identified.
Practical Algorithm
Assess for clinical triggers (hypotension, tachycardia, tachypnea, confusion, rigors, lactic acidosis, leukocytosis/leukopenia, bandemia ≥10%, thrombocytopenia)
If ANY trigger present: Treat as potential sepsis regardless of temperature
- Obtain blood cultures
- Initiate empirical antibiotics
- Pursue source identification
If high-risk population (elderly, immunocompromised, end-stage organ disease): Lower threshold for workup
- Consider procalcitonin in immunosuppressed patients 4
- Maintain high index of suspicion
If no triggers and low-risk: Clinical observation without automatic testing 1
The evidence consistently demonstrates that clinical assessment trumps temperature measurement in determining who needs infection workup 1, 3.